News

The top reasons Ozempic users are going to the hospital — and the ‘Wild West’ factor that could be driving an unexpected issue
Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...
Applied Clinical Trials Online17h
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...
Weight-Loss Drugs Have Sent a Shocking Number of People to the Emergency Room, New Study Claims
A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...
HealthDay on MSN14h
Semaglutide Beneficial in Metabolic Dysfunction-Associated Steatohepatitis, Fibrosis
For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with ...
Managed Healthcare Executive10h
FDA Sets Action Date for Oral Wegovy for Weight Loss
A decision is expected in the fourth quarter of 2025.
Healio1d
Semaglutide tied to significant improvements in MASH, liver fibrosis at 72 weeks
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...
Ozempic is growing in popularity — it’s also sending people to the ER
An analysis of emergency visits related to the active ingredient in drugs like Ozempic and Wegovy have exposed a surprising ...
Shed pounds before summer for just $50 with this semaglutide weight loss program
Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...